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Background: In general the prediction of the toxicity and therapeutic efficacy of engineered nanoparticles in
humans is initially determined using in vitro static cell culture assays. However, such test systems may not be
sufficient for testing nanoparticles intended for intravenous application. Once injected, these nanoparticles are
caught up in the blood stream in vivo and are therefore in continuous movement. Physical forces such as shear
stress and cyclic stretch caused by the pulsatile blood flow are known to change the phenotype of endothelial
cells which line the luminal side of the vasculature and thus may be able to affect cell-nanoparticle interactions.
Methods: In this study we investigated the uptake of amorphous silica nanoparticles in primary endothelial cells
(HUVEC) cultured under physiological cyclic stretch conditions (1 Hz, 5% stretch) and compared this to cells in a
standard static cell culture system. The toxicity of varying concentrations was assessed using cell viability and
cytotoxicity studies. Nanoparticles were also characterized for the induction of an inflammatory response. Changes
to cell morphology was evaluated in cells by examining actin and PECAM staining patterns and the amounts of
nanoparticles taken up under the different culture conditions by evaluation of intracellular fluorescence. The
expression profile of 26 stress-related was determined by microarray analysis.
Results: The results show that cytotoxicity to endothelial cells caused by silica nanoparticles is not significantly
altered under stretch compared to static culture conditions. Nevertheless, cells cultured under stretch internalize
fewer nanoparticles. The data indicate that the decrease of nanoparticle content in stretched cells was not due to
the induction of cell stress, inflammation processes or an enhanced exocytosis but rather a result of decreased
endocytosis.
Conclusions: In conclusion, this study shows that while the toxic impact of silica nanoparticles is not altered by
stretch this dynamic model demonstrates altered cellular uptake of nanoparticles under physiologically relevant
in vitro cell culture models. In particular for the development of nanoparticles for biomedical applications such
improved in vitro cell culture models may play a pivotal role in the reduction of animal experiments and
development costs.
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In recent years the use of nanoparticles has become
of interest in different scientific applications, such as
medicine (drug delivery, diagnostics) [1,2], biomaterial
science [3] or cell/tumor biology [4-6]. Thus, not only
detailed physico-chemical characterization of nanoma-
terials is essential but also the assessment of the poten-
tial nanotoxicological impact on animals and humans.
Due to the high number of newly synthesized materials
and the requirement for rapid and convenient high-
throughput screening of nanoparticle-cell interactions,
in vitro cell experiments are used to evaluate the effects
of nanoparticulate material on organisms. For a more
detailed investigation of nanomaterials regarding their
fate within organs, cells, or even cellular organelles, as
well as transport properties through biological barriers
(e.g., air-blood, or blood–brain barrier) more complex
cell models have been developed [7-11]. These co- or
triple-culture model systems consist of different cell
types that exhibit a more physiological phenotype as
a result of cell-cell interactions. These model systems are
closer to the in vivo situation and thus more relevant
for detailed investigation of nanoparticle-cell interactions
in vitro especially when primary cells are used [12]. Al-
though using such primary cell culture model systems is
highly recommended they cannot completely mimic the
in vivo situation. In particular, cells which are under per-
manent dynamic conditions, such as muscle cells, epithe-
lial cells of the lung, vascular smooth muscle cells or
endothelial cells making up blood vessels should be ex-
amined and analyzed in in vitro model systems that
mimic the interactions of cells with nanoparticles under
more physiological conditions. Endothelial cells that line
the luminal side of the vasculature are exposed to
hemodynamic forces such as cyclic strain and shear stress,
caused by blood pressure and blood flow [13-16]. Since
these mechanical stimuli have been identified as central
modulators of vascular cell morphology and function,
many studies have been published which describe the
cellular processes regulating cell proliferation, apoptosis,
differentiation, morphology, migration and secretory func-
tion [13,17]. Most of these studies focus on pathophysio-
logical conditions and in vitro models have been set up to
study, for example, atherosclerosis or intimal hyperplasia
([18], reviewed by [17]).
On account of the importance of in vivo-like experi-
mental conditions and the reproducibility of cell culture
experiments, the focus of the present study is the use of
a stretch system to investigate the interaction of silica
nanoparticles with primary human endothelial cells mim-
icking physiological conditions of the blood vessel. We
used amorphous silica nanoparticles (aSNP; sicastar-redF)
as model nanoparticles with different sizes (30 nm and
70 nm), but also investigated the impact of differentsurface modifications (−COOH, −NH2; or -OH) on cyto-
toxicity and uptake behavior of cells under various culture
conditions. Although aSNPs are used in food additive and
cosmetics, several studies have shown that aSNPs may
have toxic effects on cells depending on concentration,
morphology or size [19-21]. These nanoparticles can also
have an effect on cells, which are not in direct contact
with the nanoparticles but are influenced through a para-
crine pathway [8]. In the investigation presented here we
evaluate if more physiological conditions in the form of
biomechanical stress compared to static conditions will
change the results of nanoparticle toxicology assessment
and the interaction of nanoparticles with cells. Moreover,
the question will be addressed of whether changes need to
be made to adapt standard in vitro experiments to more
physiological models to achieve a more precise prediction
of NP uptake in vivo using in vitro experiments.
Results
Particle characterization
Sicastar-redF nanoparticles with different sizes and vari-
ous surface modifications were used as model nano-
particles in this study. We determined the sizes of the
various amorphous silica nanoparticles (aSNPs) in differ-
ent media by DLS. The data in Table 1 show that for the
particles with a nominal size of 70 nm and regardless
of their surface modification no significant changes in
size occurred even after prolonged incubation times of
24 hours. In contrast, the 30 nm particles tended to ag-
glomerate with time. Nevertheless, even under the high
salinity conditions of the cell culture medium the overall
colloidal stability remained similar and no macroscopic
precipitation occurred.
Impact of aSNPs on cell viability and secretion of
proinflammatory cytokines
After the physico-chemical characterization of the aSNPs
the potential toxicity on primary human umbilical vein
endothelial cells (HUVEC) was determined by using cell
viability and cytotoxicity assays. The EC50 and LD50 values
for HUVEC treated with various concentrations of aSNPs
ranging from 0 to 6000 μg/ml on plastic cell culture dishes
was determined (Additional file 1). The EC50 and LD50
values are summarized in Additional file 1 C. Based on
this, concentrations of aSNPs that were not-toxic were
used in all further studies. In addition, we demonstrated
that aSNPs were free of endotoxin using an assay system
described by Unger et al. [22], which is as sensitive as the
commonly used Limulus Amebocyte Lysate (LAL) assay.
It enables the detection of upregulated E-selectin expres-
sion on the surface of activated endothelial cells even if
the nanoparticle suspension contains traces of LPS (see
Additional file 2) [22]. Finally, HUVEC were seeded on
flexible membranes, were grown for 48 hours under either
Table 1 Determination of sicastar-redF nanoparticle sizes in water and cell culture medium at different time points
Diluent Time 30 plain 70 plain 70-COOH 70-NH2
Dh/nm SD (%) Dh/nm SD (%) Dh/nm SD (%) Dh/nm SD (%)
H2O 0 h 29.6 24 63.6 22 62.6 23 65.5 26
medium 63.7 59 63.5 13 61.0 11 62.8 10
H2O 24 h 33.0 14 72.2 22 64.1 10 66.0 10
medium 116.0 69 73.6 20 64.8 10 68.6 11
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before being treated with aSNPs for a further 24 hours
(30 nm: 60 μg/ml or 70 nm: 150 μg/ml). The impact of
aSNPs on endothelial cells was determined under two dif-
ferent culture conditions (static and stretch).
In Figure 1A the cell viability of HUVEC treated with
aSNPs under static or stretch conditions is shown. Cell
viability was measured by the bioreduction of tetrazo-
lium compound into a formazan product (MTS-assay)
in metabolically active cells. The results demonstrate
that stretch compared to static conditions did not affect
cell viability of HUVEC regardless of whether the cellsFigure 1 Impact of stretch and nanoparticle treatment on cell viability a
HUVEC were seeded on flexible membranes and treated with sicastar-redF
nanoparticles for 24 hours. (A) The MTS-Assay was used to determine cell v
control. (B) Cytotoxicity was determined by LDH-assay and data were norm
by ELISA. LPS-stimulated cells were used as positive control. (D) Soluble vas
the secretion of sVCAM after LPS treatment was used as positive control. Re
three independent experiments. For cell viability: *: P <0.05, **: P <0.01 co
Dunnetts t-test); for IL-8 secretion: ***: P <0.001 (TWOway ANOVA with Bohave been additionally treated or not with 30 nm or
70 nm aSNPs for 24 hours (Figure 1A). Nevertheless,
compared to the appropriate stretched and untreated
control cell viability of HUVEC, which have been
stretched and then treated with 70 nm particles was sig-
nificantly decreased up to 77% (±12%). The same results
were observed for cells which have been treated with
surface-modified 70 nm particles under static conditions
(70 - COOH: 88% ±6%; 70 - NH2: 84% ±8%). In contrast
the 70 nm - plain nanoparticles did not significantly affect
the cell viability under static conditions compared to the
untreated control. In addition, 30 nm particles did notnd cytotoxicity and the expression of pro-inflammatory mediators.
30 nm-plain (60 μg/ml) or various 70 nm (150 μg/ml) sicastar-redF
iability and the acquired data were normalized to the untreated static
alized to static lysis. (C) Secretion of Interleukin- (IL-) 8 was investigated
cular cell adhesion molecule (sVCAM) was determined by ELISA, while
sults shown are means ± SD calculated using the results of at least
mpared to the appropriate untreated control (ONEway ANOVA with
nferroni post-test).
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stretched or cultured under static conditions compared to
the respective untreated controls. In addition to the MTS
assay cell toxicity was also determined after treatment
with the various nanoparticles by measuring the release of
lactate dehydrogenase into the culture medium from cells
with a damaged membrane (Figure 1B). It was found that
neither the 30 nm nor the 70 nm aSNPs caused any cyto-
toxic effects, even in combination with stretch compared
to the static untreated cells. In addition to the determin-
ation of cytotoxic effects, the protein expression of pro-
inflammatory mediators (Interleukin-8 (IL-8), soluble vas-
cular cell adhesion molecule (sVCAM)) was investigated
using ELISA. The results shown in Figure 1C, D demon-
strate that aSNPs in the concentrations used did not in-
crease the secretion of the chemokine IL-8 in HUVEC
(Figure 1C). The various conditions under which HUVEC
were cultured and treated did not affect the secretion of
IL-8, even when cells were incubated with various aSNPs
in parallel. Furthermore, the secretion of sVCAM during
stretch conditions and nanoparticle treatment was not en-
hanced compared to the untreated control (Figure 1D). A
moderate but not significant increase in the secretion of
sVCAM was observed under stretch conditions and the
simultaneous treatment of HUVEC with 70-COOH silica
particles. In addition to the data shown in Figure 1C, D
the secretion of interleukin-6 (IL-6) and soluble intercellu-
lar cell adhesion molecule (sICAM) has been investigated
(data not shown). The data obtained confirmed that endo-
thelial cells under different culture conditions and after
the treatment with various aSNPs did not show any pro-
inflammatory response compared to the untreated cells.Figure 2 Internalization of silica nanoparticles into HUVEC under stat
membranes and grown to confluence under different culture conditions (s
nanoparticles (red) under static (A–D) or stretch (E–H) conditions for 24 ho
Cell nuclei were stained with Hoechst dye (blue) and the membrane assoc
(green). Fluorescent microscopy was performed with a DeltaVision-microscInternalization of aSNPs into HUVEC under different
culture conditions
In order to determine if effects were observed on the
morphology of endothelial cells microscopic images were
obtained after treatment with the nanoparticles under
the different culture conditions (Figure 2). The represen-
tative images shown in Figure 2 demonstrate that the
morphology of HUVEC is more elongated when cultured
under physiological stretch conditions while the static
cultured endothelial cells exhibit a morphology which is
mostly referred to as a ‘cobblestone’-like morphology.
Even though cells are elongated under stretched condi-
tions, they are well connected to the neighbouring cells
and express the cell adhesion molecule CD31 at the cell
periphery similar to cells cultured under static condi-
tions. However, more aSNPs are internalized under static
conditions compared to the cells grown under dynamic
stretch condition. 30 nm-plain aSNPs are internalized in
a higher amount compared to the 70 nm-plain aSNPs
and nanoparticles with a carboxylated surface are prefer-
entially internalized by endothelial cells compared to
70 nm-plain or –NH2 aSNP.
Internalization of aSNP into HUVEC under static, stretch
and mixed culture conditions
The functionality status of endothelial cells, static versus
stretched and the conditions of exposure to the nano-
particles were also examined. In this case, cells that had
been cultivated under stretch or static conditions were
treated with NPs under these conditions or transferred
to the other condition (static - static, static - stretch,
stretch - static, stretch - stretch). In Figure 3A theic and stretch culture conditions. HUVEC were seeded on flexible
tatic or stretch conditions). Afterwards cells were treated with silica
urs. Cells were washed and afterwards fixed with paraformaldehyde.
iated CD31 with the appropriate primary and secondary antibodies
ope and a with the same exposure times. Scale bar: 15 μm.
Figure 3 Image analysis of internalized silica nanoparticles into HUVEC under static, stretch and mixed culture conditions. (A) HUVEC
cultivated on flexible membranes under static (i + ii) and stretch (iii + iv) conditions were treated with silica nanoparticles under static (i + iv) or
stretch (ii + iii) conditions for 24 hours. Cells were extensively washed, fixed and stained (CD31 (green)). Cell nuclei were counterstained with
Hoechst dye (blue). Scale bar: 15 μm. (B) Images were used to quantify the cell number and the fluorescent signal coming from internalized silica
nanoparticles within the cells using Keyence analyzing software (4 images each). Results shown are means ± SD.
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Figure 3A i and A iii the results of the basic conditions
are presented which have already been described above
(Figure 2). Under static treatment conditions more parti-
cles were internalized by the cells compared to the
stretch conditions. The quantification of the fluorescent
signals within the cells confirmed these observations
(Figure 3 B; orange and dark grey bars). Taken to-
gether and based on the culture-treatment conditions
(Figure 3A (ii + iv)) and the analysis in Figure 3B it is ap-
parent that the treatment condition under which the cells
were incubated with nanoparticles is relevant and influ-
ences the amount of internalized nanoparticles. However,
the results also show that the pre-cultivation of cells
under different conditions also has an impact on the
amount of internalized nanoparticles even though the
differences in uptake under ‘static-static’ (orange) and
‘stretch-static’ (yellow) or ‘stretch-stretch’ (dark grey)
and ‘static-stretch’ (grey) conditions is not so obvious
(Figure 3A and B). Representative images of other nano-
particles internalized under the four different conditions
are depicted in Additional file 3. The combined summary
of the results indicates that the differences in the amount
of nanoparticle uptake under stretch and static condi-
tions is due to the conditions under which nanoparticles
interact with cells (static or stretch). Nevertheless, the al-
tered and more differentiated phenotype of HUVEC ob-
served under stretch conditions also appears to play a
pivotal role in the internalization process of silica nano-
particles into HUVEC.Investigation of the mechanism of altered nanoparticle
uptake under stretch culture conditions
The mechanisms which could lead to an altered uptake
behavior under physiological in vitro conditions were
investigated. First, cell stress caused by cyclic strain as a
potential modulator of endocytosis was analyzed. The
expression profile of 26 cell stress-related proteins of
stretched and unstretched cells has been investigated
at protein level. Selected protein levels are shown in
Figure 4C. None of the proteins examined showed an
altered expression in HUVEC grown under stretch con-
ditions compared to static culture conditions. Neither
apoptotic-related proteins (Bcl-2) nor transcription fac-
tors NFƙB and hypoxia-induced factors (HIFs) were in-
duced under the physiological culture conditions. In
addition to the unchanged expression of the transcription
factor HIF, the protein levels of related downstream
metabolites which are involved in extracellular cellular
matrix metabolism such as MMP-9 remained unaltered.
In Figure 4A the actin filaments of the cells cultured
under various conditions are shown. In Figure 4A (i - iii)
it can be seen that actin is located at the cell borders and
is co-localized with the membrane protein, CD31 (green,
resulting in a yellow staining). Under stretch conditions
(Figure 4A (iv – vi)) the actin fibers are located within
the cell and are less co-localized with CD31. This add-
itional change in the cell morphology (more elongated
cells after stretch) shows that the stretch protocol was ef-
fective. Since it has been shown that changes in the struc-
ture of the cytoskeleton can impact membrane traffic and
Figure 4 Stretch-induced changes in morphology and expression of proteins related to cell stress and exocytotic events. (A) HUVEC
cultivated on flexible membranes under static (i – iii) and stretch (iv – vi) conditions were stained for CD31 (green) and actin (red). Cell nuclei
were counterstained with Hoechst dye (blue). Scale bar: 15 μm. (B) Quantification of secreted growth factors or inflammatory mediators under
both culture conditions detected by ELISA. (C) Comparison of the protein expression levels of cell stress- and angiogenesis-related proteins of
stretched and unstretched cells have been investigated by protein array. Results shown are means ± SD.
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the plasma membrane thereby subsequently impacting
endocytotic and exocytotic properties of cells [23-26], then
there should be different amounts of internalized nanopar-
ticles in cells as a result of an altered endocytosis or exocyt-
osis rate under static and stretch culture conditions. Since
mechanical stimuli such as stretch are known to stimulate
the secretion of several markers (endothelin-1, tissue-type
plasminogen activator, cytokines) into the cell culture
medium [27-30], we specifically analyzed the secretion of
endothelin-1 (ET-1), a relevant factor which is released
under stretch conditions by ELISA [27]. Figure 4B shows
that the secretion of ET-1 under the different conditions
was not significantly induced. Also the secretion of
interleukin-6 (IL-6) and soluble ICAM (sICAM) was not
increased under stretch conditions in culture.
To determine if the lower amount of aSNP within the
cell under stretch conditions is a result of an increased
exocytotic event and not due to decreased endocytosis,
HUVEC were treated with aSNP under static conditions
for 24 hours. Cells were extensively washed, fresh medium
was added and afterwards cells were cultured under
stretch or static conditions. After 24 hours of incubation
the supernatant was transferred to HUVEC seeded onto96 well plates for a further 24 hour period. Following this,
stretched and static cells were fixed and analyzed for inter-
nalized aSNPs by fluorescence microscopy (data not
shown). No differences in the amount of nanoparticles
within the cells were observed. The cells on the 96 well
plates, which were incubated with the supernatants of
the static and stretch plates were analyzed for the pres-
ence of internalized silica nanoparticles. In the control
cells incubated with medium no red fluorescence could
be detected. For the 70-plain and 70-NH2 aSNPs only
a slight amount of NPs could be found within the cells.
Thus, the quantification was focused on 70-COOH nano-
particles (Figure 5). In Figure 5A the images of the nano-
particle uptake by HUVEC are presented. A number of
images were quantified by image analysis of the red sig-
nal. The data indicate that the uptake properties into the
cells did not significantly differ regardless of whether the
cells were incubated with the supernatant of cells, which
have been stretched or cultured under static conditions
(Figure 5B). Thus, by measuring the secretion of ET-1 or
the internalization rate of exocytosed aSNPs it appears
that the decreased amount of aSNPs within the cells
under stretch conditions was not due to increased exo-
cytotic events.
Figure 5 Uptake and quantification of exocytosed 70 nm-COOH silica nanoparticles using a cell assay system. HUVEC seeded on flexible
membranes were treated for 24 hours with aSNPs under static conditions. NP suspension was removed, cells extensively washed, incubated with
fresh medium under flex or static condition for 24 hours. The medium including the exocytosed aSNPs was used to treat HUVEC grown onto 96
well plates for further 24 hours. Afterwards these cells were washed, fixed, and analyzed for internalized aSNPs by image analyses. (A) Representative
images of cells that internalized exocytosed aSNPs. Cell nuclei counterstained with Hoechst dye (blue). Scale bar 100 μm. (B) Quantification of relative
fluorescent intensity depicted as means of 24 images per condition.
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Nanoparticles as drug delivery systems or imaging tools
may be useful in improving biomedical therapies. The
accreditation of nanoparticles as biomedical tools usually
starts with in vitro investigations. The development of
in vitro models which mimic the in vivo situation is
highly desirable and may lead to the reduction of animal
experimentation which could subsequently reduce the
development costs for pharmaceutics. Static cell culture
is used for the determination of cell reactions, such as
toxicity or the formation of reactive oxygen species.
However, endothelial cells are permanently exposed to
hemodynamic forces such as shear stress and cyclic
stretch [15]. Although the effect of shear stress has been
investigated [31-34], the current study focusses on the
effects of sterile, endotoxin-free sicastar-redF nanoparti-
cles on endothelial cells under stretch culture condi-
tions. Amorphous silica nanoparticles (aSNPs) of various
sizes and surface modifications appear to affect endothe-
lial cells differently under static and stretch cell culture
conditions. It was also shown that cytotoxic effects were
not altered, although the internalization of the aSNPs
under various culture conditions differed.
The characterization of the NPs used was the first step
in the present investigations. The data presented in
Table 1 show that the characteristics of the nanoparticles
diluted in the cell culture medium used are comparable
to previously reported studies [35]. The presence of serum
proteins gives rise to a slight agglomeration and mean par-
ticle diameters in the range of 100–200 nm were mea-
sured (data not shown). This behavior is in accordance
with the expectations: The formation of a protein coronagives rise to a disturbance of the mechanism of colloidal
stabilization of the particles (electrostatic stabilization)
and results in the formation of agglomerates [36,37].
The determination of potential toxic effects of aSNPs
under various culture conditions was also analyzed. Inter-
estingly, the impact of the aSNPs on HUVEC was not
significantly increased under stretch conditions com-
pared to the static conditions and may be due to the
application of a non-pathophysiological stretch (5% stretch,
1 Hz) [38-40]. The reduction of the metabolic activity of
HUVEC after exposure to 70 nm-COOH or 70 nm-NH2
aSNPs may be due to the high internalization rate of these
nanoparticles. However, no toxicity was detected after
24 hours of exposure (LDH assay). Regarding the 30 nm-
and 70 nm-plain aSNPs, the results are in accordance
with the data measured for endothelial cells (ISO-HAS-1)
previously published by our group [35]. Furthermore,
Nabeshi et al. also determined an impact of 30 nm and
70 nm sicastar-redF particles on the proliferation of
HaCaT cells after 24 hours of incubation [41]. However,
the toxic effect on cells under physiological stretch con-
ditions was not investigated. In addition, the unaltered
secretion of IL-8 and sVCAM by HUVEC under vari-
ous culture conditions and simultaneous treatment with
NPs show that neither the applied stretch nor the
nanoparticles activate an inflammatory response in
endothelial cells. Nevertheless, the cells that were treated
with LPS under stretch show a significantly increased
IL-8 secretion compared to the cells treated with LPS
under static conditions, which might be due to the more
physiological character of these cells under stretched
conditions.
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physiological stretch conditions less aSNPs were inter-
nalized by HUVEC compared to static cell culture
conditions. To our knowledge, the correlation of cyclic
stretch and internalization of nanoparticles into endo-
thelial cells has not been reported previously. Rouse
et al. examined the effects of quantum dots (QD) on
keratinocytes under stretch conditions and found that
the interaction of QD and keratinocytes (HEK) was
increased under cyclic strain [42]. Unfortunately, the
mechanisms behind the altered uptake behavior of QD
into HEK were not further investigated. Many studies
have reported the effects of stretch on the phenotype
and protein expression profile of HUVEC, but these
studies usually focused on hypertension (≥10%) [39] of
endothelial cells which mimics a pathological condition
in endothelial cells, e.g. arteriosclerosis [18] and not
cells under normal conditions. In the present study
the physiological elongation of 5% was investigated to
determine if the differences in the uptake properties of
aSNPs are due to a more physiological and differentiated
cell phenotype, inflammatory responses and cell stress or
are a result of a higher exocytosis rate of the cells grown
and treated under stretch conditions. The results of the
studies demonstrated that the treatment condition has
greater impact on the interaction effects of the aSNPs on
the cells than a more differentiated and stretch-adapted
phenotype of the cells (comparison of the four culture-
treatment conditions). In addition, a pre-incubation of
cells under stretch has a small impact on the uptake rate
of aSNPs into HUVEC. Therefore, it appears that the
changed morphology and phenotype of the ECs prior to
exposure to NPs plays a secondary role in the uptake of
aSNP into HUVEC in vitro. An analysis of the most prom-
inent stress mediators of ECs by a protein array demon-
strated that cell stress factors were not mediators involved
in influencing the uptake behavior of aSNPs under stretch
conditions. Various studies have shown that cellular stress
impacts the endocytotic rate of metabolites [43,44]. Since
no enhanced cell stress factors under stretch conditions
could be detected it appears that these factors are not re-
sponsible for the decreased endocytosis of the aSNPs. Fur-
thermore, studies of HUVEC under stretch conditions
indicated that stretching cells results in a decreased endo-
cytosis and an increased exocytosis rate of the cells which
apparently counteracts the membrane tension caused by
stretch [45]. This increased exocytosis rate can be indir-
ectly measured by an enhanced secretion of growth factors
such as tissue plasminogen activator or endothelin-1
[27,46-49]. However, a comparison of the amount of the
secretion of ET-1 under flex and static cell culture did not
exhibit significant differences in the amount of ET-1 after
applying 5% stretch. The discrepancy may be due to the
amount of stretch applied or the time points which werechosen for the measurement of ET-1. To determine if
aSNPs are exocytosed more efficiently under stretch con-
ditions as a consequence of counteracting the membrane
tension studies were undertaken to determine if more
aSNPs are released under stretch conditions. This was
found not to be the case and is contrary to the results of
the uptake of exocytosed NPs in static culture of HUVEC
(Figure 5). A net increase of exocytotic events could not
be detected and thus the decrease in endocytotic events
might be responsible for the results observed. The model
described by Sinha et al. may explain the lower amount
of endocytotic events [50]. The model defines that under
certain conditions the stretch of membranes will be coun-
teracted by the flattening of caveolae. Following the flat-
tening process of the membrane by the disappearance of
caveolae it is likely that a decreased endocytosis and in-
creased exocytosis are counteracting the stretch and
complete the initial response at longer time periods of
stretch. Due to the physiological stretch applied flattening
of the membrane with subsequent caveolae disappearance
could be an explanation why the exocytosis rate in our
studies, analyzed by ET-1 secretion and aSNP exocytosis,
is not altered under the two different culture conditions.
Thus, increased exocytosis is not responsible for the lower
number of particles within the cells but membrane flatten-
ing could be the reason for less endocytotic events during
stretch. However, previous studies have analyzed the cell
entry mechanisms of aSNPs and no co-localization of
aSNPs with caveolin-1 or clathrin-heavy chain was ob-
served. However, localization with flotillins, apparently
responsible for the uptake of NPs by caveolin- and
clathrin-independent mechanisms were observed for NPs
in endothelial and lung epithelial cells [9,35]. Moreover,
the mechanism of flotillin-dependent uptake is similar to
caveolae-dependent endocytosis [51], and therefore, mem-
brane flattening might also affect the flotillin-controlled
uptake mechanism.
Further studies also demonstrated that the arrange-
ment of actin fibers differ in stretch cultured cells com-
pared to static cultured cells. This demonstrates that
cells are morphologically affected by the applied stretch
and that the elongation by 5% leads to a slight alteration
in the cytoskeleton arrangement and the cell morphology
which is comparable to the situation in vivo [52,53]. The
effects on the cytoskeleton caused by stretch also play a
pivotal role in mechanotransduction [24,26,28,54]. Due to
the strong attachment of the cytoskeleton and the plasma
membrane, changes in the arrangement of the cytoskel-
eton also affect endocytotic events [45,55]. Han et al.
showed that flow also affects the cytoskeletal arrangement
and that this occurrence is related to an altered uptake of
spherical polystyrene particles coated with PECAM anti-
bodies [34]. Thus, the direct influence of stretch due to
the membrane (flattening process) and the rearrangement
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aSNP in HUVEC in a concerted manner.
Other explanations are possible for the altered intern-
alization of aSNPs observed in these studies under static
and stretch conditions. Since the expression of factors
which are involved in extracellular matrix (ECM) metab-
olism are also known to be induced by stretch, the
interaction of nanoparticles and the cell membrane of
HUVEC might be affected with the resulting conse-
quence being an altered uptake rate of nanoparticles
under stretch conditions. We have demonstrated that
matrix metalloproteinases-9 expression is unaltered
under stretch and also the expression of transcription
factors (e.g. HIFs), which can induce the expression of
MMPs, is not induced. The expression of MMP-2 and
collagen type I and IV have been analyzed on protein
level but no significant differences could be detected
(data not shown). Nevertheless, by adapting in vitro experi-
ments to more in vivo-like conditions a development of a
more in vivo-like ECM and a polarization of cells may
occur which may also change the interaction of NPs and
cell membranes. The consequences of this could be an al-
tered internalization rate of NPs into cells. In addition the
sedimentation of the nanoparticles may be a prominent
factor impacting the uptake processes and is dependent on
the nanoparticle interaction with the membrane [56]. This
might alter the uptake rate of aSNP into HUVEC under
stretch, since the stretch conditions applied might lead to
medium movement above the cells. However, this move-
ment of NPs above the cells would mimic the movement
of NPs in blood as it occurs in vivo.
The results of these in vitro studies demonstrate that
in vitro test systems have to be adapted to more physio-
logical conditions that mimic in vivo conditions more
closely. These studies have also shown that differences
occur with four highly similar but slightly modified
aSNPs in their interactions with HUVEC under certain
stretch conditions. Further studies, such as changing the
frequency, time, elongation, the type of endothelial cells
and testing different NPs will be necessary to give a
more complete picture of how stretch affects the uptake
of nanoparticles into endothelial cells. A device to inves-
tigate in parallel the impact of stretch and shear stress
on nanoparticle uptake and transport across lung cells
has been published by Huh et al. [57]. Such a 3D organ-
on-a-chip model adapted to other organs would be a
valuable addition to evaluating the impact of shear stress
and stretch on nanoparticle uptake in unique cell types
and may lead to reduction of animal studies.
Conclusions
In conclusion the present study shows that in addition
to shear stress, cyclic stretch also affect the interaction
of nanoparticles and endothelial cells and such systemsshould be highly relevant for designing specific targeted
nanoparticulate drug delivery strategies.
Methods
Particle characterization
Silica nanoparticles (aSNP; sicastar-redF) were pur-
chased from micromod Partikeltechnologie GmbH,
Rostock (Germany). All particles were fluorescently la-
belled (λex =585 nm) and particle diameters were 30 nm
and 70 nm. The larger particles were purchased not only
with plain silica surface (Si–OH/Si–O−), but also with
carboxy-(−COOH) and with amine-(−NH2) modified
surface to examine the influence of surface properties. Par-
ticle sizes were determined by Dynamic Light Scattering
(DLS), and thus, the reported sizes are z-weighted mean
values of the hydrodynamic diameter. Particle diameters
were measured in cell culture medium (Endothelial Cell
Basal Medium (ECBM); PromoCell) and, for reference, in
water (containing 2 mmol/L sodium bromide to guarantee
optimum colloidal stability). Two time points were chosen
(0 and 24 hours), representing the start and the end point
of the cell experiment. DLS measurements were performed
using a Microtrac NANO-flex instrument (with a 180°
backscattering setup). The data analysis mode “Monodis-
perse” was used for the evaluation of the measurements.
Further characteristics of the particles such as number of
nanoparticle per milliliter or per milligram can be found
on the manufacture’s homepage (www.micromod.de). Fur-
ther data of the nanoparticle characteristics are summa-
rized in Additional file 4.
Cell isolation and culture
Umbilical cords were obtained from randomly selected
healthy mothers. All procedures were in agreement with
the ethical standards of the University Medical Center of
the Johannes-Gutenberg University Mainz (§ 14 AVB,
Abs. 3) and with the Helsinki Declaration. Primary
human umbilical vein endothelial cells (HUVEC) were
isolated according to a previously published method
[58,59]. Cells were cultured in medium M199 (Sigma
Aldrich), 20% fetal calf serum (Life Technologies), 2 mM
Glutamax I (Life Technologies), 100 U/100 mg/ml
penicillin/streptomycin, 25 mg/ml sodium heparin (Sigma-
Aldrich) and 25 mg/ml endothelial cell growth factor
supplement (ECGS, Becton Dickinson) on gelatin-coated
cell culture flasks (greiner bio-one) upon isolation. After
the first passage cells were cultured in ECBM, 15% fetal
calf serum, 2.5 ng/mL basal fibroblast growth factor,
10 μg/mL sodium heparin (both Sigma-Aldrich) and
100 U/100 mg/ml penicillin/streptomycin (hereinafter
referred to as ECBM culture medium) on gelatin-coated
cell culture flasks. Cells were used for the experiments in
passage 2–4 and are cultured under standard cell culture
conditions (5% CO2, 95% humidity, 37°C).
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Cells were seeded onto fibronectin-coated 96-well plates
in ECBM culture medium and cultured to confluence.
Cells were exposed to various concentrations of aSNPs
for 24 hours. The nanoparticles were diluted in ECBM,
supplement mix (PromoCell) and 100 U/100 mg/ml
penicillin/streptomycin (hereinafter referred to ECBM
stimulation medium). Cell viability was measured using
the CellTiter 96 AQueous non-radioactive assay (Promega)
as recommended by the manufacturer. For the detec-
tion of cytotoxicity caused by the treatment of aSNPs,
50 μl of the cell supernatant was used to carry out the
CytoTox 96 non-radioactive cytotoxicity assay (Promega).
The lactate dehydrogenase (LDH) release after cell lysis
(1% TritonX 100 (Sigma-Aldrich)) into the medium
was used to determine 100% LDH release and the re-
lease of LDH of cells, which have been treated with the
appropriate volume of nanoparticle diluent was used as
control. Particle interference with the assay systems was
not detected. After measuring cell viability cells were
washed with phosphate-buffered saline and fixed with
methanol/ethanol at room temperature for 15 minutes.
The following E-selectin determination by cell adhesion
molecule enzyme immunoassay (CAM-EIA) was per-
formed as previously described to evaluate aSNPs for the
initial screening for presence of endotoxin [22,60]. Cells
treated with 1 μg/ml lipopolysaccharide (LPS) was used as
positive control and set to 100% E-selectin expression.
The determination of cell viability and cytotoxicity for
cells cultured on flexible membranes were carried out as
described above using cells which were cultured under
stretch or static conditions and treated with 60 μg/ml
or 150 μg/ml of 30 nm or 70 nm silica nanoparticles,
respectively.
Exposure to Nanoparticles during cyclic stretch
HUVEC were seeded onto fibronectin-coated flexible
silicon membranes (BioFlex Culture Plate (FlexCell
International Corporation)) with ECBM culture medium.
24 hours after seeding, cells were exposed to cyclic
stretch for 48 hours (5% elongation (sinus) and a fre-
quency of 1 Hz) using a FX-4000 Tension Plus FlexerCell
strain unit and a FlexLink controller. This system was
connected to a base plate holder, which was equipped
with six round 25-mm loading posts and a vacuum
pump. Control cells were also seeded on the membranes
but were cultured under static conditions without any
stretching for the same time period. Cells were treated
with 60 μg/ml (6.37 × 1012 particles/well) or 150 μg/ml
(1.26 × 1012 particles/well) of 30 nm or 70 nm aSNPs, re-
spectively. We chose these concentrations to prevent an
overload of the cells with nanoparticles and applying
concentrations which have been demonstrated to benon-toxic. Nanoparticles were diluted in ECBM stimula-
tion medium. For mixed conditions cells were treated
for 48 hours under the first condition and 24 hours
(incubation time for the nanoparticles) under the second
condition.
Enzyme- linked immunosorbent assay (ELISA)
After exposure to the nanoparticles under different cul-
ture conditions the supernatants of the cells were diluted
in the appropriate diluent and analyzed via ELISA (DuoSet,
R&D Systems) for secreted soluble pro-inflammatory me-
diators or growth factors (sVCAM, sICAM, IL-8, IL-6, and
endothelin-1) as recommended by the manufacturer.
Immunofluorescent staining, microscopy, and image
quantification
After treatment with nanoparticles, membranes with
HUVEC were washed repeatedly with HEPES buffer and
PBS, fixed with 3.7% paraformaldehyde for 15 minutes
and stained with specific antibodies. For staining of the
cell membrane, mouse anti-human PECAM-1 (CD-31;
Dako) was used. Nuclei were counterstained with Hoechst
33342 dye (Sigma-Aldrich). The membranes were embed-
ded with GelMount (Biomeda, Natutec) and analyzed via
fluorescence microscopy (Olympus IX71 with Delta Vision
system (Applied Precision) or BZ9000 (Keyence)). To
analyze the amount of internalized nanoparticles, images
were taken with BZ9000 (20x objective) using the same
magnification and exposure times. BZ Analyzer software
(Keyence) was used to count cell nuclei and to determine
the relative fluorescent intensity.
Cellular stress and angiogenesis array
The expression profile of stretch and static cell culture
of HUVECs was investigated for proteins related to cell
stress or angiogenesis using the Human Cell Stress
Array Kit or Human Angiogenesis Array Kit (both R&D
Systems) according to methods recommended by the
manufacturer. The protein concentration of each sample
was determined using the BCA protein assay kit (Pierce).
Data analysis
GraphPad Prism version 5.04 software (Prism) was used
for data analysis.
Additional files
Additional file 1: Determination of EC50 and LD50 of various aSNPs
in Huvec. (A) HUVEC were treated with various nanoparticles in a
concentration range of 0 to 6000 μg/ml for 24 hours and EC50 was
determined by MTS assay. Untreated cells were set to 100% cell viability
(B) The supernatant of the cells was examined for the amount of released
LDH to determine the LD50. Lysed cells were used as positive control and
set to 100%. (C) Summary of EC50 and LD50 for the various aSNPs.
(donors ≥3).
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endotoxin contamination of the nanoparticles. HUVEC were grown
on 96-well plates and treated with 60 μg/ml 30 nm-plain or 150 μg/ml
70 nm aSNPs for 4 hours. Cells were washed, fixed and E-selectin expression
was determined by CAM-EIA as described by Unger et al. 2014 (see
references). 1 μg/ml lipopolysaccharide was used as positive control
and set to 100% E-selectin expression while untreated cells were used as
negative control. (2 donors in triplicate).
Additional file 3: Uptake of various aSNPs into HUVEC under static,
stretch and mixed culture conditions. HUVEC cultivated on flexible
membranes under static (a + b) and stretch (c + d) conditions were
treated with silica nanoparticles under static (a + d) or stretch (b + c)
conditions for 24 hours. Cells were extensively washed, fixed and stained
(CD31 (green)). Cell nuclei were counterstained with Hoechst dye (blue).
Scale bar: 15 μm.
Additional file 4: Nanoparticle characteristics provided by the
manufacturer (www.micromod.de).
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